about
Hepatotoxicity Induced by "the 3Ks": Kava, Kratom and KhatAnalysis of gene expression changes of drug metabolizing enzymes in the livers of F344 rats following oral treatment with kava extractImmunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extractEthnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources.Use of complementary and alternative medicine in a large sample of anxiety patients.Herbs in hemato-oncological care: an evidence-based review of data on efficacy, safety, and drug interactions.Herbal Insomnia Medications that Target GABAergic Systems: A Review of the Psychopharmacological Evidence.Kava: a comprehensive review of efficacy, safety, and psychopharmacology.Neurocognitive effects of kava (Piper methysticum): a systematic review.Ginkgo biloba extract induces gene expression changes in xenobiotics metabolism and the Myc-centered networkMethysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypesDietary feeding of Flavokawain A, a Kava chalcone, exhibits a satisfactory safety profile and its association with enhancement of phase II enzymes in mice.The use of selected nutrition supplements and complementary and alternative medicine in liver disease.Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides.Toxicity of kava kava.Natural product taking its own place!!!Current diagnosis and treatment of anxiety disorders.Hepatotoxic slimming aids and other herbal hepatotoxins.Effects of botanical dietary supplements on cardiovascular, cognitive, and metabolic function in males and females.Kava, a tonic for relieving the irrational development of natural preventive agents.Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.Quality assurance and safety of herbal dietary supplements.Gene expression profiling as an initial approach for mechanistic studies of toxicity and tumorigenicity of herbal plants and herbal dietary supplements.Deleterious effects of reactive metabolites.Bioactivation of herbal constituents: simple alerts in the complex system.Diets, phytochemicals, and chemoprevention of tumorigenesis.The flavokawains: uprising medicinal chalcones.Drug-induced hepatotoxicity of select herbal therapies.Management of side effects during and post-treatment in breast cancer survivors.Toxicokinetics of kava.Herbal medicines and acute medical emergency admissions to hospital.Kava for the treatment of generalized anxiety disorder RCT: analysis of adverse reactions, liver function, addiction, and sexual effects.An international pilot study of oncology physicians' opinions and practices on Complementary and Alternative Medicine (CAM).Identification of C-glycoside flavonoids as potential mutagenic compounds in kava.Kavalactone metabolism in rat liver microsomes.A stable isotope dilution tandem mass spectrometry method of major kavalactones and its applications.Evaluation of How Integrative Oncology Services Are Valued between Hematology/Oncology Patients and Hematologists/Oncologists at a Tertiary Care Center.
P2860
Q26752375-CCA7BB46-FDA8-4FD8-BBE5-D7BE360B470DQ28567320-8FF9A48E-CD8A-49C5-BD7D-BEE6CC197B16Q28577347-B3754E62-0496-4169-92A1-149E56D74094Q30396823-94BA8301-4606-439C-B42E-7F0CF266F3B1Q33583404-EAA402D4-1C0E-4593-9252-1BD77310EE1EQ33596382-CA169BD8-C5B6-44AA-B022-E9FE7ED74482Q33621705-304E2880-F4F4-42F5-8720-402FFABFC9F1Q33745578-D653024C-097F-488F-9336-9CA2EE1C7E45Q33856072-F284987E-6706-4D83-9460-7165A61F1BA1Q34030746-2CDC8E76-953D-4F12-BD43-988CCC4A240EQ34215362-30D2E007-F05F-4994-8EF1-9E22205695DAQ34419646-EA5B0B04-2BDA-4E27-8179-CC100C3DF68CQ34449318-9C4E2D32-46B0-4020-AC04-7FD3890135DBQ34554574-AEE407C5-4DAB-4188-B77F-FE388EEEE01BQ34558540-7FF89CF3-1D64-400F-B6BF-7BBEE2D64BCBQ34759111-DEB03A56-8AD2-48B2-AD1A-AA0DFAF4A943Q35117223-9E813710-C14D-4993-B760-C4A88A5832A8Q36771550-0B151344-5669-463A-B1C8-F184256818DEQ37101690-DCD86DFD-C23F-465F-A17A-9F408E60F983Q37131844-D3E6DA8B-7F90-4A6F-A009-4F7DF6A18060Q37175348-E15BF3F2-8529-4F64-A812-D159CCFFF123Q37375043-25CAEE7F-B2E5-4B5A-87F1-E347B1848A7FQ37468723-3E5DA631-6217-48AD-AD9E-2992B7188242Q37730719-C0096084-DB94-48F9-BC9F-3F9E7D29F6EDQ37802740-2664BAB4-8E3E-43DE-9F25-7D5379BBFB7EQ37879144-2EECB373-9A82-4651-8B07-3979AD58E7B2Q37995233-834D929A-95F5-4959-BCCD-66DC1C360D91Q38154682-51A7DAE8-4907-44A3-9FCB-673D080EE010Q38302838-3E993B0D-B799-41FF-BC2B-125D81BBF478Q38636806-95F27ACE-8D41-428C-8E7A-0F01BE8C81B2Q41763713-871B57B6-496B-4207-A58F-F9E24CE24A86Q42538565-7DB8CE52-76D0-4B79-B0C2-315354613F52Q44595110-7804E4A7-6CE3-43B7-9364-9126FA640B20Q46304316-39598C48-9F4E-4873-808D-E654CBCE5E5DQ46905469-5CA94CB1-C795-46BB-A1D7-C1A8D4F05224Q51324784-4B0646CF-E68C-4F95-8F72-1D0B96F8DF67Q55279019-30DDE5D7-ED8F-4830-9BC2-A75F3ADE298BQ55334671-E5667C76-72BF-45DB-8703-A4283F20D3BB
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Kava kava: examining new reports of toxicity.
@ast
Kava kava: examining new reports of toxicity.
@en
type
label
Kava kava: examining new reports of toxicity.
@ast
Kava kava: examining new reports of toxicity.
@en
prefLabel
Kava kava: examining new reports of toxicity.
@ast
Kava kava: examining new reports of toxicity.
@en
P1433
P1476
Kava kava: examining new reports of toxicity.
@en
P2093
Dallas L Clouatre
P356
10.1016/J.TOXLET.2003.07.005
P577
2004-04-01T00:00:00Z